摘要
本文论述了红细胞载体的特性和应用概况等的研究进展。通过总结近年来国内外相关文献资料,认为红细胞载体具有极为重要的临床应用意义和广阔的应用、开发前景。
出处
《北方药学》
2014年第9期76-77,共2页
Journal of North Pharmacy
参考文献10
-
1Carmen Lizano, Teresa PM,Montserrat Pinilla. Mouse erythro- cytes as carriers for co encapsulated alcohol and aldehyde dehy- drogenate obtained by electro oration In vivo survival rate in circu- lation organ distribution and ethanol degradation[J]. Life Sciences, 2001,68 : 2001.
-
2王学琦,杨佳,刘访杰,周海平.红细胞作载体的谷胱甘肽过氧化物酶用于脑缺血-再灌注的研究[J].中国病理生理杂志,1998,14(3):266-269. 被引量:10
-
3彭丽华.甲氨碟呤红细胞载体对肝癌模型大鼠肝肾功能影响观察[J].中国中医药现代远程教育,2012,10(1):149-149. 被引量:3
-
4Luigia Rossi. Erythrocyte-mediated delivery of a new hemodin- ucleotide active against human immunodeficiency virus and herpes simplex virus[J]. J of Antimicrobial Chemotherapy, 2001,47:819.
-
5Tonetti M,Zocchi E, Guida L,etal. Use of glutaraldehyde treat- ed autologous erythrocytes for hepatic targeting of doxorubicin. In: M agnani,DeLoach,Editors. Advances in experimental medicine and biology|J1. New York:Plenum Press, 1992,326 : 307.
-
6汪小海,朱世俊,骆璇,徐鑫.红细胞作为吗啡载体的包蔽效果、术后镇痛时效及药代动力学研究[J].数理医药学杂志,2000,13(5):439-441. 被引量:6
-
7Luigia Rossi. Erythrocytem-ediated Delivery of Dexamethasone in Patients with Chronic Obstructive Pulmonary Disease [J]. Biotechno 1.App 1.Biochem, 2001,33 : 85.
-
8Rossi L. Increase Glucose Metabolism by Enzyme-loaded Ery- throcytes in vitro and in vivo Normalization of Hyperglycemia in Diabetic Mice[J]. Biotechnol Appl Biochem, 1992, 15:207.
-
9Mishra PR,Jain NK. Biotinylated methotrexate loaded erythro- eytes for enhanced liver uptake. A study on the rat [J]. Inter J Pharmaceutics, 2002,231 (2) : 145.
-
10De Flora A,Zoochi E,Gukla L,et al.Conversion of Encapsu- lated 5-Fluoro-2'-Deoxyuridine-5'- Monophosphate to the An- tineoplastic Drug 5-Fluoro-2-Deoxyuridine in Human Erythro- cvtes[J]. Pro Natl ACL Sci, 1988,85 : 31-34.
二级参考文献5
-
1宋祥福,吕喆,刘欣,杨海山.两种方式接种肝癌模型的比较[J].中国比较医学杂志,2007,17(2):96-98. 被引量:14
-
2葛卫红,袁盛华,霍晶,汪小海.正交实验设计优化甲氨蝶呤红细胞载体制备工艺[J].药学与临床研究,2007,15(4):285-287. 被引量:4
-
3张之南,中华血液学杂志,1987年,8卷,12期,729页
-
4袁盛华,霍晶,葛卫红,王璐璐,汪小海.甲氨蝶呤红细胞载体在大鼠体内药动学研究[J].中国新药杂志,2008,17(15):1308-1310. 被引量:7
-
5Sun Lihong, Department of Acupuncture, Hebei College of Traditional Chinese Medicine, Hebei Province 050091, ChinaWang Sunjiang,Feng Shuping, Department of Urosurgery, Handan District Hospital, Hebei Province 056001, China.ACUPUNCTURE ANAESTHESIA IN TREATING URINARY TRACT STONE WITH EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY[J].World Journal of Acupuncture-Moxibustion,1993,3(3):34-36. 被引量:1
共引文献16
-
1杨阳,刘宝瑞,钱晓萍.载体红细胞及其靶向化疗的研究进展[J].医学研究生学报,2004,17(11):1015-1018. 被引量:1
-
2王宣,钱宝华,郭峰.红细胞载体的应用研究进展[J].深圳中西医结合杂志,2005,15(1):61-63. 被引量:1
-
3李小利,江振友.NO与GSH-PX在HIE的含量测定及临床意义[J].中国现代医学杂志,2005,15(12):1867-1869. 被引量:1
-
4刘玉梅,张润玲,苏海翔.新生儿缺氧缺血性脑病血谷胱甘肽过氧化物酶水平与DNA损伤的关系探讨[J].国外医学(临床生物化学与检验学分册),2005,26(12):879-881. 被引量:1
-
5柯蒙.红细胞药物载体研究进展[J].海峡药学,2007,19(2):7-9.
-
6李敏遐,李伟明,候燕明,徐辉,关永东,刘杰雄.HIE患儿血浆谷胱甘肽过氧化物酶的变化及意义[J].实用医学杂志,2001,17(2):104-105. 被引量:6
-
7李敏遐,侯燕明,徐辉.还原型谷胱甘肽对新生儿缺氧缺血性脑病的治疗作用[J].广东医学,2001,22(3):207-208. 被引量:7
-
8李伟明,徐辉,李敏遐,侯燕明,关永东.新生儿缺氧缺血性脑病NO、GSH-PX和TNF的含量测定及其临床意义[J].中国急救医学,2001,21(9):509-511. 被引量:5
-
9李伟明,徐辉,李敏遐,侯燕明,关永东.新生儿缺氧缺血性脑病患儿NO和TNF变化及临床意义[J].实用医学杂志,2001,17(9):811-813.
-
10席芸,钱晓萍,刘宝瑞.载体红细胞在抗肿瘤治疗中应用的进展[J].东南大学学报(医学版),2014,33(5):626-629. 被引量:3
同被引文献25
-
1Yann G, Francoise H, Robert F, et al. International seminar on the red blood cells as vehicles for drugs [J]. Expert Opin Biol Ther, 2012, 12(1): 127-133.
-
2Agrawal V, Hee WJ, Borthakur G, et al. Red blood cell-encapsu- lated L-asparaginase: potential therapy of patients with aspara- gine synthetase deficient acute myeloid leukemia [J]. Protein & Peptide Letters, 2013, 20(4): 392-402.
-
3Magnani M, Rossi L. Approaches to erythrocyte-mediated drug delivery [J].Expert Opin Drug Deliv, 2014, 11(5): 677-687.
-
4Banz A, Cremel M, Mouvant A, et al. Tumor growth control us- ing red blood cells as the antigen delivery system and poly(l:C) [J]. Jlmmunother, 2012, 35(5): 409-17.
-
5Gupta N, Patel B, Ahsan F. Nano-engineered erthrocyte ghosts as inhalational carriers for delivery of fasudil: preparation and characterization [J]. Pharm Res, 2014, 31(6): 1553-1565.
-
6Chiarantini L, Cerasi A, Fraternale A, et al. Comparison of nov- el delivery systems for antisense peptide nucleic acids [J]. J Control Release, 2005, 109(1): 24-36.
-
7Shi G, Mukthavaram R, Kesari S, et al. Distearoylanchor-paint- ed erythrocytes with prolonged ligand retention and circulation properties in vivo [J]. Adv Health Mater, 2014, 3(1): 142-148.
-
8Cinti C, Taranta M, Naldi I, et al. Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds [J]. PLoS One, 2011, 6(2): e 17132.
-
9Luk BT, Hu CM, Fang RH, et al. Interfacial Interactions be- tween Natural RBC Membranes and Synthetic Polymeric Nanoparticles [J]. Nanoscale, 2014, 6(5): 2730-2737.
-
10Aryal S, Hu CMJ, Fang RH, et al. Erythrocyte mem- brane-cloaked polymeric nanoparticles for controlled drug loading and release [J]. Nanomedicine, 2013, 8(8): 1271-1280.
二级引证文献2
-
1马弘扬,马雪松,丛玉双,戚思华.库存血水浴复温的研究进展[J].医学综述,2017,23(16):3216-3220. 被引量:7
-
2胡扬,成秉辰,王金宏,王昊,王福玲,贾玉翠,郑佩玉,张艳君,杨波.裙带菜多糖对S180荷瘤小鼠红细胞内[Ca2+]的影响[J].哈尔滨商业大学学报(自然科学版),2018,34(5):513-515.
-
1王宣,钱宝华,郭峰.红细胞载体的应用研究进展[J].深圳中西医结合杂志,2005,15(1):61-63. 被引量:1
-
2葛卫红,连燕舒,康学军,汪小海.吗啡红细胞载体在兔体内的药代动力学[J].中国药科大学学报,2006,37(2):150-152. 被引量:3
-
3张建中.抗组胺药物的特性和应用[J].中国全科医学,2004,7(12):891-892. 被引量:2
-
4连燕舒,康学军,张建新,葛卫红,李琦.反相离子对高效液相色谱法测定血浆吗啡含量[J].中国医院药学杂志,2003,23(8):467-469. 被引量:4
-
5赵晓贞.复方甘草酸苷治疗过敏性紫癜的临床应用意义评析[J].中国实用医药,2016,11(26):207-208. 被引量:2
-
6柯军.药师对临床不合理用药的药学干预分析[J].健康导报(医学版),2015,20(5):93-93.
-
7葛卫红,连燕舒,骆璇,彭婕,马虹.吗啡红细胞载体用于胸部手术后镇痛的初步临床研究[J].中国新药杂志,2007,16(15):1215-1217. 被引量:2
-
8汪小海,徐鑫,葛卫红.梗阻性黄疸患者吗啡-红细胞载体时效及药代动力学特征[J].临床麻醉学杂志,2007,23(10):809-811. 被引量:1
-
9王宣,李炳汝,羡秋盛,傅强.国内红细胞载体文献的计量学分析[J].实用医药杂志,2007,24(12):1516-1518. 被引量:1
-
10霍晶,葛卫红,方芸,袁盛华.红细胞包载抗肿瘤药物研究进展[J].中国药房,2007,18(10):784-786. 被引量:2